Catch up on news from Murrieta Genomics by checking out our April 2020 newsletter here.
Catch up on news from Murrieta Genomics by checking out our April 2020 newsletter here.
Like everyone, we are doing what we can to keep ourselves and those we love safe during this trying time.
Today we launched our newsletter, a monthly update to keep everyone in the loop. You can view it here.
John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with
“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are
Company Filed Second Patent Application to Extend Core Technology Applications
Murrieta Genomics is pleased to announce that U.S. Patent and Trademark
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,
“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will
The University of California system has four campuses within a close drive from Murrieta Genomics. We are actively working with the Riverside, San Diego and Los Angeles campuses, and will be providing more information on intellectual property in the near future.
More information coming soon, this space will contain information about the products or services that your company provides, this space will contain information about the products or services that your company provides.
More information coming soon, this space will contain information about the products or services that your company provides, this space will contain information about the products or services that your company provides.